Tissue-resident memory features are linked to the magnitude of cytotoxic T cell responses in human lung cancer.

Tissue-resident memory features are linked to the magnitude of cytotoxic T cell responses in human lung cancer.
复制标题

DOI:
10.1038/ni.3775
复制
发表时间:
2017-08
期刊:
影响因子:
30.5
通讯作者:
Ottensmeier CH
Ottensmeier CH
中科院分区:
医学1区
文献类型:
--
作者:
Ganesan AP;Clarke J;Wood O;Garrido-Martin EM;Chee SJ;Mellows T;Samaniego-Castruita D;Singh D;Seumois G;Alzetani A;Woo E;Friedmann PS;King EV;Thomas GJ;Sanchez-Elsner T;Vijayanand P;Ottensmeier CH

文献摘要

参考文献

被引文献

相似文献

增强细胞毒性T淋巴细胞(CTL)的抗肿瘤应答的疗法已显示出希望;然而,对目前可用的免疫抑制剂的临床应答差异很大,并且其分子基础尚不清楚。我们对来自未经治疗的肺癌患者的肿瘤浸润性CTL进行了转录组学分析,以确定与抗肿瘤免疫应答的稳健性相关的分子特征。我们观察到与T细胞抗原受体(TCR)活化相关的分子和免疫检查点分子(如4-1BB、PD-1和TIM-3)的表达存在相当大的异质性。具有高密度CTL的肿瘤显示与组织驻留记忆细胞(TRM细胞)(例如CD 103)连接的转录物的富集,并且来自CD 103 hi肿瘤的CTL显示增强的细胞毒性的特征。肿瘤中TRM细胞密度越大,预示着肺癌的生存结局越好,这种效应与CTL密度无关。在这里,我们定义了肿瘤浸润性CTL的“分子指纹”,并确定了免疫治疗的潜在新靶点。
Therapies that boost the anti-tumor responses of cytotoxic T lymphocytes (CTLs) have shown promise; however, clinical responses to the immunotherapeutic agents currently available vary considerably, and the molecular basis of this is unclear. We performed transcriptomic profiling of tumor-infiltrating CTLs from treatment-naive patients with lung cancer to define the molecular features associated with the robustness of anti-tumor immune responses. We observed considerable heterogeneity in the expression of molecules associated with activation of the T cell antigen receptor (TCR) and of immunological-checkpoint molecules such as 4-1BB, PD-1 and TIM-3. Tumors with a high density of CTLs showed enrichment for transcripts linked to tissue-resident memory cells (TRM cells), such as CD103, and CTLs from CD103hi tumors displayed features of enhanced cytotoxicity. A greater density of TRM cells in tumors was predictive of a better survival outcome in lung cancer, and this effect was independent of that conferred by CTL density. Here we define the ‘molecular fingerprint’ of tumor-infiltrating CTLs and identify potentially new targets for immunotherapy.
DOI: 10.1038/ni.2536
发表时间: 2013-04
期刊: Nature immunology
影响因子: 30.5
作者:
通讯作者: --
DOI: 10.4049/jimmunol.1402711
发表时间: 2015-04-01
影响因子: 4.4
作者:
Djenidi, Faycal;Adam, Julien;Mami-Chouaib, Fathia
通讯作者: Mami-Chouaib, Fathia
DOI: 10.1158/0008-5472.can-07-2282
发表时间: 2008-02-01
期刊: CANCER RESEARCH
影响因子: 11.2
作者:
Montes, Carolina L.;Chapoval, Andrei I.;Gastman, Brian R.
通讯作者: Gastman, Brian R.
DOI: 10.1172/jci46102
发表时间: 2011-06-01
影响因子: 15.9
作者:
Baitsch, Lukas;Baumgaertner, Petra;Speiser, Daniel E.
通讯作者: Speiser, Daniel E.
DOI: 10.1016/j.ccell.2014.10.018
发表时间: 2014-12-08
期刊: CANCER CELL
影响因子: 50.3
作者:
Johnston, Robert J.;Comps-Agrar, Laetitia;Grogan, Jane L.
通讯作者: Grogan, Jane L.